| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1261.37 | 96 |
| GSM780708 | Untreated after 4 days (C2_1) | 733.948 | 94 |
| GSM780709 | Untreated after 4 days (C3_1) | 771.622 | 94 |
| GSM780719 | Untreated after 4 days (C1_2) | 1242.94 | 96 |
| GSM780720 | Untreated after 4 days (C2_2) | 840.957 | 95 |
| GSM780721 | Untreated after 4 days (C3_2) | 746.997 | 94 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 692.972 | 94 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1201.81 | 96 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 981.237 | 95 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 653.634 | 93 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1115.57 | 96 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1196.12 | 96 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1380.66 | 97 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 823.947 | 95 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1234.26 | 96 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1588.49 | 97 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 892.457 | 95 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1214.63 | 96 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1493.12 | 97 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1150.67 | 96 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1063.97 | 96 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1440.81 | 97 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1065.82 | 96 |